Spruce Biosciences logo
Spruce Biosciences SPRB
€ 34.61 -6.84%
report update icon

Quartalsbericht 2026-Q3
hinzugefügt 09.11.2026

Spruce Biosciences DSO | SPRB

DSO Vierteljährlich Spruce Biosciences

2026-Q1 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - - - - - - - - - 316 348 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
348 316 332

DSO anderer Aktien in der Pharmaeinzelhändler

Name DSO Preis % 24h Marktkapitalisierung Land
Taro Pharmaceutical Industries Ltd. Taro Pharmaceutical Industries Ltd.
TARO
143 - - $ 1.62 B israelIsrael
Omeros Corporation Omeros Corporation
OMER
667 $ 13.23 -5.71 % $ 840 M usaUSA
PhaseBio Pharmaceuticals PhaseBio Pharmaceuticals
PHAS
191 - 7.4 % $ 6.29 M usaUSA
Forma Therapeutics Holdings Forma Therapeutics Holdings
FMTX
5.57 - - $ 958 M usaUSA
Blueprint Medicines Corporation Blueprint Medicines Corporation
BPMC
42.5 - - $ 8.14 B usaUSA
Horizon Therapeutics Public Limited Company Horizon Therapeutics Public Limited Company
HZNP
65.8 - - $ 26.6 B irlandaIrlanda
Provention Bio Provention Bio
PRVB
19.2 - - $ 2.37 B usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
28.1 $ 1.44 -2.03 % $ 2.37 M israelIsrael
PolarityTE PolarityTE
PTE
219 - -0.82 % $ 1.78 M usaUSA
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
1.3 K $ 39.15 0.57 % $ 3.52 B schweizSchweiz
Advaxis Advaxis
ADXS
3.28 K - -9.65 % $ 45.9 M usaUSA
Stoke Therapeutics Stoke Therapeutics
STOK
7.52 $ 26.77 -0.59 % $ 1.59 B usaUSA
Trevena Trevena
TRVN
22.9 - -46.58 % $ 31.8 M usaUSA
Calithera Biosciences Calithera Biosciences
CALA
28.8 - -10.95 % $ 876 K usaUSA
Molecular Templates Molecular Templates
MTEM
4.53 - -23.43 % $ 495 K usaUSA
BioXcel Therapeutics BioXcel Therapeutics
BTAI
103 $ 0.07 9.81 % $ 855 K usaUSA
Novan Novan
NOVN
204 - -24.84 % $ 2.64 M usaUSA
NeuBase Therapeutics NeuBase Therapeutics
NBSE
-65.8 - -1.56 % $ 12.3 M usaUSA
Epizyme Epizyme
EPZM
47.2 - - $ 249 M usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
8.16 K - -6.81 % $ 3.04 B usaUSA
Nabriva Therapeutics plc Nabriva Therapeutics plc
NBRV
59.2 - - $ 4.55 M irlandaIrlanda
scPharmaceuticals scPharmaceuticals
SCPH
81.4 - - $ 218 M usaUSA
Athersys Athersys
ATHX
73 - 3.77 % $ 22.4 M usaUSA
Global Blood Therapeutics Global Blood Therapeutics
GBT
43.4 - - $ 4.62 B usaUSA
NanoString Technologies NanoString Technologies
NSTG
103 - -37.43 % $ 5.1 M usaUSA
Humanigen Humanigen
HGEN
598 - -81.12 % $ 4.28 M usaUSA
Sorrento Therapeutics Sorrento Therapeutics
SRNE
125 - -29.58 % $ 126 M usaUSA
Surface Oncology Surface Oncology
SURF
7.98 - - $ 59.7 M usaUSA
Vaccinex Vaccinex
VCNX
546 - -61.37 % $ 654 K usaUSA
Nymox Pharmaceutical Corporation Nymox Pharmaceutical Corporation
NYMX
12.5 - -19.68 % $ 18.4 M canadaCanada
Jounce Therapeutics Jounce Therapeutics
JNCE
2.32 - - $ 98.4 M usaUSA
Cocrystal Pharma Cocrystal Pharma
COCP
101 $ 0.93 -4.11 % $ 10.5 M usaUSA
Fortress Biotech Fortress Biotech
FBIO
115 $ 1.89 6.78 % $ 52.7 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
48.3 - -24.86 % $ 820 K usaUSA
Longeveron Longeveron
LGVN
28.6 $ 1.65 -9.34 % $ 29 B usaUSA